Former Novartis India Chief Ranjit Shahani no more

Published On 2024-03-11 09:52 GMT   |   Update On 2024-03-20 10:43 GMT

New Delhi: Former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, Ranjit Shahani has passed away.Shahani was a Mechanical Engineering degree holder from the Indian Institute of Technology, Kanpur and an MBA from Jamnalal Bajaj Institute of Management Studies in Mumbai, as per Hardvard's official website,He led various roles in his lifetime. Beginning...

Login or Register to read the full article

New Delhi: Former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, Ranjit Shahani has passed away.

Shahani was a Mechanical Engineering degree holder from the Indian Institute of Technology, Kanpur and an MBA from Jamnalal Bajaj Institute of Management Studies in Mumbai, as per Hardvard's official website,

He led various roles in his lifetime. Beginning from working in Imperial Chemical Industries (ICI) in India, where he contributed to fibres and speciality chemicals and later held position of General Manager at ICI, Zeneca in the UK, overseeing Asia Pacific and Latin American operations for their petrochemicals and plastics division. 

He took his next step towards his phenomenal career by joining Roche Products Limited where he served as a CEO. After Roche, he joined Novartis India Limited in 1997. Shahani served as the Managing Director and Vice Chairman at Novartis India from 2001 to 2018. 

He was also the President Emeritus of the Organisation of Pharmaceutical Producers of India (OPPI) and President of the Swiss Indian Chamber of Commerce India. Shahani also chaired advisory boards at JB Chemicals and Pharmaceuticals, served as a director on the boards of Hikal Ltd and Ambuja Cements Ltd.

Read also: Britain health regulator revokes conditional marketing authorisation for Novartis sickle cell drug Adakveo



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News